Chinese nasal spray, inhaled COVID-19 vaccines undergoing clinical trial: Official
BEIJING -- Clinical trials of China-developed nasal spray and inhaled COVID-19 vaccines are currently underway, according to the National Health Commission.
The nasal spray has been selected as one of China's vaccine technologies to combat COVID-19 in the very beginning, Zeng Yixin, deputy head of the commission, said in a recent interview.
Medical experts will study the safety and effectiveness of the tested vaccines after completing the collection of clinical trial data, Zeng added.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


